Autem Therapeutics
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- $10M
Investors
- 1
About Autem Therapeutics
Based in New Hampshire, US, and founded in 2017 by CEO Michael Choukas, and CSO Frederico Costa, Autem Therapeutics LLC is developing a novel bioelectric oncology treatment platform to deliver low-level, amplitude-modulated electromagnetic (EM) frequency for the treatment of hepatocellular carcinoma (HCC) and other solid tumor cancers. As of July 2022, Michael Choukas is the CEO of Autem Therapeutics. The company provides AutEMsys, a therapy that delivers personalized, amplitude-modulated electromagnetic (EM) frequencies to patients systemically to shrink tumors as well as enhance the quality of life and extend survival in early and advanced stage patient populations.
Who invested in Autem Therapeutics
1 investor across 1 round
See all investors in Autem Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 6, 2022
Amount
$10M
Investors
Questions about Autem Therapeutics
Who invested in Autem Therapeutics?
Autem Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Autem Therapeutics raised?
Autem Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Autem Therapeutics last raise money?
Autem Therapeutics's most recent round on record is a Series A, in Jun 2022.
What does Autem Therapeutics do?
Based in New Hampshire, US, and founded in 2017 by CEO Michael Choukas, and CSO Frederico Costa, Autem Therapeutics LLC is developing a novel bioelectric oncology treatment platform to deliver low-level, amplitude-modulated electromagnetic (EM) frequency for the treatment of hepatocellular carcinoma (HCC) and other solid tumor cancers.
Where is Autem Therapeutics headquartered?
Autem Therapeutics is headquartered in Hanover, US.
Which VCs invest in companies like Autem Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Autem Therapeutics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Autem Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.